Evidence map›Paper›PMID 33769856›Full record

ArticleJournal of managed care & specialty pharmacy2021

Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension.

Arsène Zongo, Scot Simpson, Jeffrey A Johnson, Dean T Eurich

Open access · bronzeAbstract read
PubMed Full text at PMC
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Arsène ZongoSchool of Public Health, University of Alberta, Edmonton, Canada; Faculty of Pharmacy, Université Laval, Quebec City, Canada; and Population Health and Optimal Health Practices Research Unit, CHU de Québec, Université Laval Research Centre, Quebec City, Canada.
Scot SimpsonFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Jeffrey A JohnsonSchool of Public Health, University of Alberta, Edmonton, Canada.
Dean T EurichSchool of Public Health, University of Alberta, Edmonton, Canada.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic DiseasePatient Care PlanningPatient CompliancePharmaceutical ServicesAgedCanadaCohort StudiesFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionMaleMiddle AgedOutcome Assessment, Health CareHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID33769856
PMCPMC10390929
OpenAlexW3136296759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.